Priya U. Kumthekar, MD
Northwestern Medical GroupIs your insurance accepted? Select plan
Accepts your insurance
Does not accept your insurance
Based on January 2024 plan details.
Accepted plans are subject to change. To be sure this medical professional is covered by your insurance plan, please contact your insurance carrier.
If your carrier is not listed, your insurance is likely not accepted. Please contact your insurance carrier to be sure if this medical professional accepts your insurance.
Practice Focus Areas
- Brain Metastases
- Brain Tumors
- Medulloblastoma
- Rare Central Nervous System Tumors
- Spinal Cord Tumors
Education
- Medical Education:
-
MD, Northeast Ohio Medical University College of Medicine - 2007
- Internship:
-
McGaw Medical Center of Northwestern University - 2008
- Residency:
-
McGaw Medical Center of Northwestern University - 2011
- Fellowships:
-
McGaw Medical Center of Northwestern University - 2012
Languages Spoken
- Spanish
Board Certifications
- American Board of Psychiatry and Neurology - Neurology (Certified)
- United Council for Neurologic Subspecialties - Neuro-Oncology (Certified)
Faculty Profile
Associate Professor, Feinberg School of MedicinePractice Groups and Affiliations
- Medical Group:
- Northwestern Medical Group
- Alignment Category:
-
Northwestern Medicine Physician Network
- On Medical Staff At:
-
Central DuPage HospitalDelnor HospitalHuntley HospitalMcHenry HospitalNorthwestern Lake Forest HospitalNorthwestern Memorial HospitalWoodstock Hospital
Ratings and Reviews
At Northwestern Medicine, our patient’s feedback is important to us. While different care providers have their own unique strengths, we strive to be as transparent as possible with our quality of care.
Read Ratings FAQsOverall Rating
490 Ratings
Reviews from Patients
Reviews from Patients
Disclosures
Industry Relationships
Ownership or Investment Interests
Faculty member had an ownership or investment interest in the following companies
- Datix Limited
- Vivacitas Oncology, Inc.
Consulting / Related Activities
Faculty member engaged in activities such as speaking, advising, consulting, or providing educational programs for the following companies or other entities
- Affinia Healthcare
- Belay Diagnostics
- Biocept, Inc.
- BioClinica
- Biodexa Pharmaceuticals PLC
- BPGbio, Inc.
- Brown & James, PC
- Enclear Therapies, Inc.
- IN8BIO, Inc.
- Janssen Pharmaceuticals, Inc.
- Novocure, Inc.
- Plus Therapeutics, Inc.
- Seagen, inc
- Servier Pharmaceuticals
- Telix
Royalty Payments and Inventor Share
Faculty member has the right to receive payments or may receive future financial benefits for inventions or discoveries related to the following companies or other entities
- Angiochem, Inc.
Service on Board of Directors
Faculty member served in a fiduciary capacity, such as a board member/director, officer, or trustee, for the following companies or other entities
- BPGbio, Inc.
- IN8BIO, Inc.
External Professional Relationships
Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.
Chrome
Edge
Safari
Firefox